David Johnson
Net worth: 195 608 $ as of 2026-10-30
Net worth: 195 608 $ as of 2026-10-30
David L.
Johnson is currently an Independent Director at Caribou Biosciences, Inc. since 2022 and Chief Operating Officer at Vera Therapeutics, Inc. since 2024.
Formerly, Mr. Johnson was Vice President-Sales & Marketing at Gilead Sciences, Inc. from 2003 to 2018 and Chief Commercial Officer at Global Blood Therapeutics, Inc. from 2018 to 2022.
Education includes an undergraduate degree from the University of Puget Sound and an MBA from Kenan-Flagler Business School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-23 | 6,314 ( 0.01% ) | 195 608 $ | 2026-10-30 | |
| 2026-04-19 | 0 ( -.--% ) | - $ | 2026-10-30 |
| Companies | Position | Start |
|---|---|---|
| VERA THERAPEUTICS, INC. | Chief Operating Officer | 2024-06-30 |
| CARIBOU BIOSCIENCES, INC. | Director/Board Member | 2022-05-10 |
| Companies | Position | End |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 2022-11-30 |
| GILEAD SCIENCES, INC. | Sales & Marketing | 2017-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Caribou Biosciences, Inc.
Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of Puget Sound
University of Puget Sound Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kenan-Flagler Business School
Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions